Egetis Therapeutics AB (publ) Capital Reinvestment Ratio

Latest as of June 2011: 1.30x

Egetis Therapeutics AB (publ) capital reinvestment ratio. Egetis Therapeutics AB (publ) (EGTX) has a Capital Reinvestment Ratio of 1.30x as of June 2011, meaning it reinvests 1% of its operating cash flow (Skr1.84 Million) in capital expenditures (Skr2.38 Million). Check Egetis Therapeutics AB (publ) total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

1.30x

Capex / Operating Cash Flow

Operating Cash Flow

Skr1.84 Million

SEK

Capital Expenditures

Skr2.38 Million

SEK

Data as of

Jun 2011

Most recent filing

Egetis Therapeutics AB (publ) Capital Reinvestment Ratio by Year (None–None)

Egetis Therapeutics AB (publ) capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see EGTX cash generation efficiency.

Year	Reinvestment Ratio	Operating CF (SEK)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow